Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 592 | 5,078 | 0 | 0 | 0 |
| Gross Profit | 592 | 5,078 | N/A | N/A | N/A |
| Operating Expenses | 2,142 | 2,201 | 56,306 | 2,419 | 2,132 |
| Operating Income | -1,550 | 2,877 | -56,306 | -2,419 | -2,132 |
| Interest Expense | 5 | 6 | 2 | 0 | 24 |
| Other Income | 40 | 100 | -102 | 68 | 259 |
| Pre-tax Income | -1,515 | 2,971 | -56,410 | -2,351 | -1,897 |
| Income Tax | N/A | N/A | -12,126 | -483 | -554 |
| Net Income Continuous | -1,515 | 2,971 | -44,284 | -1,868 | -1,343 |
| Net Income | $-1,515 | $2,971 | $-44,284 | $-1,868 | $-1,343 |
| EPS Basic Total Ops | -0.60 | 1.20 | -18.97 | -0.72 | -0.60 |
| EPS Basic Continuous Ops | -0.58 | 1.18 | -18.93 | -0.75 | -0.58 |
| EPS Diluted Total Ops | -0.60 | 1.20 | -18.97 | -0.72 | -0.60 |
| EPS Diluted Continuous Ops | -0.58 | 1.17 | -18.93 | -0.75 | -0.58 |
| EBITDA(a) | $-1,571 | $2,943 | $-56,296 | $-2,408 | $-2,118 |